Citius Pharmaceuticals, Inc. Proceeds from (Repayments of) Bank Overdrafts
Citius Pharmaceuticals, Inc. (CTXR) reported Proceeds from (Repayments of) Bank Overdrafts of -$9 for the 9-month period ending 2014-06-30, per its 10-Q filed 2014-08-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfBankOverdrafts · last filed 2014-08-14
- Citius Pharmaceuticals, Inc. proceeds from (repayments of) bank overdrafts for the quarter ending 2014-06-30 was $0.00.
- Citius Pharmaceuticals, Inc. proceeds from (repayments of) bank overdrafts for the quarter ending 2014-03-31 was $0.00.
- Citius Pharmaceuticals, Inc. proceeds from (repayments of) bank overdrafts for the quarter ending 2013-12-31 was -$9.00.
- Citius Pharmaceuticals, Inc. proceeds from (repayments of) bank overdrafts for the quarter ending 2013-09-30 was $9.00.
- Citius Pharmaceuticals, Inc. proceeds from (repayments of) bank overdrafts for fiscal 2013 was $9.00.
- Citius Pharmaceuticals, Inc. proceeds from (repayments of) bank overdrafts for fiscal 2012 was $0.00.
| Period end | Proceeds from (Repayments of) Bank Overdrafts 3 month | Proceeds from (Repayments of) Bank Overdrafts 6 month | Proceeds from (Repayments of) Bank Overdrafts 9 month | Proceeds from (Repayments of) Bank Overdrafts 12 month | Proceeds from (Repayments of) Bank Overdrafts 37 month | Proceeds from (Repayments of) Bank Overdrafts 40 month | Proceeds from (Repayments of) Bank Overdrafts 43 month |
|---|---|---|---|---|---|---|---|
| 2014-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-14 | $0.00 derived: sum of 2 quarters · filed 2014-08-14 | -$9.00 10-Q · filed 2014-08-14 | $0.00 derived: sum of 4 quarters · filed 2014-08-14 | |||
| 2014-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-15 | -$9.00 10-Q · filed 2014-05-15 | $0.00 derived: sum of 3 quarters · filed 2014-05-15 | $0.00 derived: sum of 4 quarters · filed 2014-08-14 | $0.00 10-Q · filed 2014-05-15 | ||
| 2013-12-31 | -$9.00 10-Q · filed 2014-02-19 | $0.00 derived: sum of 2 quarters · filed 2014-02-19 | $0.00 derived: sum of 3 quarters · filed 2014-08-14 | $0.00 derived: sum of 4 quarters · filed 2014-08-14 | $0.00 10-Q · filed 2014-02-19 | ||
| 2013-09-30 | $9.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | $9.00 derived: sum of 2 quarters · filed 2014-08-14 | $9.00 derived: sum of 3 quarters · filed 2014-08-14 | $9.00 10-K · filed 2014-02-06 | $9.00 10-K · filed 2014-02-06 | ||
| 2013-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-14 | $0.00 derived: sum of 2 quarters · filed 2014-08-14 | $0.00 10-Q · filed 2014-08-14 | ||||
| 2013-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-15 | $0.00 10-Q · filed 2014-05-15 | |||||
| 2012-12-31 | $0.00 10-Q · filed 2014-02-19 | ||||||
| 2012-09-30 | $0.00 10-K · filed 2014-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |